Shilpa Medicare Ltd (NSE:SHILPAMED)

Q3 2026 Shilpa Medicare Ltd Earnings Call Transcript

Feb 6, 2026 / 10:30 AM GMT

Release Date Price: ₹315.9

Transcript

Key Points

Positve

Shilpa Medicare Ltd (BOM:530549) reported the highest ever quarterly revenue of 411 crores, marking a 28% year-on-year growth.
The company achieved its highest ever quarterly EBITDA at 115 crores, reflecting a robust growth of 41% compared to the previous year.
The formulation business showed significant growth, with revenues for the quarter at 177 crores, growing at 50% year-on-year.
The company has successfully received marketing authorization for its first transdermal patch product, Rotigoti, with plans to launch in 2027.
Shilpa Medicare Ltd (BOM:530549) is seeing good traction in its Europe market, with nilotinib showing strong volume growth quarter on quarter.

Negative

The company's licensing income revenue is down by over 40% on a nine-month basis compared to the previous year.
There are concerns about the non-oncology API segment's capacity utilization, indicating room for improvement in scaling up.
The oncology segment has struggled to consistently surpass the 140-150 crore revenue mark, indicating potential challenges in growth.
The company is facing competition in the oncology API market, with new entrants gaining market share.
Shilpa Medicare Ltd (BOM:530549) has a net debt of about 625 crores as of December 31, 2025, which may impact financial flexibility.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SHME.NS - Shilpa Medicare Ltd
Q3 2026 Shilpa Medicare Ltd Earnings Call
Feb 06, 2026 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the 3 and 9 months FI26 Grizzles conference call of Shilpa Medicare Limited.

As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing then 0 on your touchtone phone.

I now hand the conference over to Mr. Mohnish Shah, head of investor relations and strategy.

Thank you and over to you, Mr. Mohnish.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.